11β-Hydroxysteroid dehydrogenase type 2 and the regulation of surfactant protein A by dexamethasone metabolites

American Journal of Physiology - Endocrinology and Metabolism

Volumn 290, Issue 4, 2006, Pages

  Garbrecht, Mark R ^a   Schmidt, Thomas J ^a   Krozowski, Zygmunt S ^b   Snyder, Jeanne M ^a,c  

^a UNIVERSITY OF IOWA   (United States)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c 1 550 Bowen Science Bldg ^*  (United States)

Author keywords

Glucocorticoid; H441 cells; Lung

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; CORTISONE; DEXAMETHASONE; GLUCOCORTICOID; HYDROXYSTEROID DEHYDROGENASE; SURFACTANT PROTEIN A; CARBENOXOLONE; CHENODEOXYCHOLIC ACID; ENZYME INHIBITOR; HSD11B1 PROTEIN, HUMAN;

ARTICLE; CELL LINE; ENZYME ACTIVITY; ENZYME REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG PARENCHYMA; METABOLITE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID METABOLISM; BIOSYNTHESIS; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; LUNG; METABOLISM; NEWBORN; PRENATAL DEVELOPMENT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL LINE; UPREGULATION;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; CARBENOXOLONE; CELL LINE, TUMOR; CHENODEOXYCHOLIC ACID; DEXAMETHASONE; ENZYME INHIBITORS; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; LUNG; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; UP-REGULATION;

EID: 33646096995     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00396.2005     Document Type: Article

References (41)

1. Effect of corticosteroids for fetal maturation on perinatal outcomes. NIH Consensus Development Panel on the Effect of Corticosteroids for Fetal Maturation on Perinatal Outcomes. JAMA 273: 413-418, 1995.
2. Abramovitz M, Branchaud CL, and Murphy BE. Cortisol-cortisone interconversion in human fetal lung: contrasting results using explant and monolayer cultures suggest that 11 beta-hydroxysteroid dehydrogenase (EC 1.1.1.146) comprises two enzymes. J Clin Endocrinol Metab 54: 563-568, 1982.
3. Abramovitz M, Carriero R, and Murphy BE. Investigation of factors influencing 11 beta-hydroxysteroid dehydrogenase (EC 1.1.1.146) activity in midgestational human fetal lung monolayer and explant cultures. J Steroid Biochem 21: 677-683, 1984.
4. Alcorn JL, Islam KN, Young PP, and Mendelson CR. Glucocorticoid inhibition of SP-A gene expression in lung type II cells is mediated via the TTF-1-binding element. Am J Physiol Lung Cell Mol Physiol 286: L767-L776, 2004.
5. Andrew R, Smith K, Jones GC, and Walker BR. Distinguishing the activities of 11beta-hydroxysteroid dehydrogenases in vivo using isotopically labeled cortisol. J Clin Endocrinol Metab 87: 277-285, 2002.
6. Atanasov AG, Tam S, Rocken JM, Baker ME, and Odermatt A. Inhibition of 11 beta-hydroxysteroid dehydrogenase type 2 by dithiocarbamates. Biochem Biophys Res Commun 308: 257-262, 2003.
7. Ballard PL, Carter JP, Graham BS, and Baxter JD. A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 41: 290-304, 1975.
8. Boggaram V, Smith ME, and Mendelson CR. Regulation of expression of the gene encoding the major surfactant protein (SP-A) in human fetal lung in vitro. Disparate effects of glucocorticoids on transcription and on mRNA stability. J Biol Chem 264: 11421-11427, 1989.
9. Bolt RJ, van Weissenbruch MM, Lafeber HN, and Delemarre-van de Waal HA. Glucocorticoids and lung development in the fetus and preterm infant. Pediatr Pulmonol 32: 76-91, 2001.
10. Cheng Y and Prusoff WH. Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochem Pharmacol 22: 3099-3108, 1973.
11. Clements JA and Avery ME. Lung surfactant and neonatal respiratory distress syndrome. Am J Respir Crit Care Med 157: S59-S66, 1998.
12. Creuwels LA, van Golde LM, and Haagsman HP. The pulmonary surfactant system: biochemical and clinical aspects. Lung 175: 1-39, 1997.
13. Crouch EC. Collectins and pulmonary host defense. Am J Respir Cell Mol Biol 19: 177-201, 1998.
14. Diederich S, Grossmann C, Hanke B, Quinkler M, Herrmann M, Bahr V, and Oelkers W. In the search for specific inhibitors of human 11beta-hydroxysteroid-dehydrogenases (11beta-HSDs): chenodeoxycholic acid selectively inhibits 11beta-HSD-I. Eur J Endocrinol 142: 200-207, 2000.
15. Diederich S, Hanke B, Burkhardt P, Muller M, Schoneshofer M, Bahr V, and Oelkers W. Metabolism of synthetic corticosteroids by 11 beta-hydroxysteroid-dehydrogenases in man. Steroids 63: 271-277, 1998.
16. Diederich S, Hanke B, Oelkers W, and Bahr V. Metabolism of dexamethasone in the human kidney: nicotinamide adenine dinucleotide-dependent 11beta-reduction. J Clin Endocrinol Metab 82: 1598-1602, 1997.
17. Diederich S, Scholz T, Eigendorff E, Bumke-Vogt C, Quinkler M, Exner P, Pfeiffer AF, Oelkers W, and Bahr V. Pharmacodynamics and pharmacokinetics of synthetic mineralocorticoids and glucocorticoids: receptor transactivation and prereceptor metabolism by 11beta-hydroxysteroid-dehydrogenases. Horm Metab Res 36: 423-429, 2004.
18. Dulkerian SJ, Gonzales LW, Ning Y, and Ballard PL. Regulation of surfactant protein D in human fetal lung. Am J Respir Cell Mol Biol 15: 781-786, 1996.
19. George TN, Miakotina OL, Goss KL, and Snyder JM. Mechanism of all trans-retinoic acid and glucocorticoid regulation of surfactant protein mRNA. Am J Physiol Lung Cell Mol Physiol 274: L560-L566, 1998.
20. George TN and Snyder JM. Regulation of surfactant protein gene expression by retinoic acid metabolites. Pediatr Res 41: 692-701, 1997.
21. Gomez-Sanchez EP, Ganjam V, Chen YJ, Liu Y, Clark SA, and Gomez-Sanchez CE. The 11beta hydroxysteroid dehydrogenase 2 exists as an inactive dimer. Steroids 66: 845-848, 2001.
22. Haataja R, Ramet M, Marttila R, and Hallman M. Surfactant proteins A and B as interactive genetic determinants of neonatal respiratory distress syndrome. Hum Mol Genet 9: 2751-2760, 2000.
23. Hammer S, Spika I, Sippl W, Jessen G, Kleuser B, Holtje HD, and Schafer-Korting M. Glucocorticoid receptor interactions with glucocorticoids: evaluation by molecular modeling and functional analysis of glucocorticoid receptor mutants. Steroids 68: 329-339, 2003.
24. Hochhaus G, Rohdewald P, Mollmann H, and Greschuchna D. Identification of glucocorticoid receptors in normal and neoplastic adult human lung. Res Exp Med (Berl) 182: 71-78, 1983.
25. Hundertmark S, Dill A, Ebert A, Zimmermann B, Kotelevtsev YV, Mullins JJ, and Seckl JR. Foetal lung maturation in 11beta-hydroxysteroid dehydrogenase type 1 knockout mice. Horm Metab Res 34: 545-549, 2002.
26. Jaskoll T, Choy HA, and Melnick M. The glucocorticoid-glucocorticoid receptor signal transduction pathway, transforming growth factor-beta, and embryonic mouse lung development in vivo. Pediatr Res 39: 749-759, 1996.
27. Krozowski Z, Li KX, Koyama K, Smith RE, Obeyesekere VR, Stein-Oakley A, Sasano H, Coulter C, Cole T, and Sheppard KE. The type I and type II 11beta-hydroxysteroid dehydrogenase enzymes. J Steroid Biochem Mol Biol 69: 391-401, 1999.
28. Krozowski Z, MaGuire JA, Stein-Oakley AN, Dowling J, Smith RE, and Andrews RK. Immunohistochemical localization of the 11 beta-hydroxysteroid dehydrogenase type II enzyme in human kidney and placenta. J Clin Endocrinol Metab 80: 2203-2209, 1995.
29. Kumar AR and Snyder JM. Differential regulation of SP-A1 and SP-A2 genes by cAMP, glucocorticoids, and insulin. Am J Physiol Lung Cell Mol Physiol 274: L177-L185, 1998.
30. Li KX, Obeyesekere VR, Krozowski ZS, and Ferrari P. Oxoreductase and dehydrogenase activities of the human and rat 11beta-hydroxysteroid dehydrogenase type 2 enzyme. Endocrinology 138: 2948-2952, 1997.
31. Liley HG, White RT, Warr RG, Benson BJ, Hawgood S, and Ballard PL. Regulation of messenger RNAs for the hydrophobic surfactant proteins in human lung. J Clin Invest 83: 1191-1197, 1989.
32. Moore XL, Hoong I, and Cole TJ. Expression of the 11beta-hydroxysteroid dehydrogenase 2 gene in the mouse. Kidney Int 57: 1307-1312, 2000.
33. Murphy BE. Cortisol production and inactivation by the human lung during gestation and infancy. J Clin Endocrinol Metab 47: 243-248, 1978.
34. Odom MJ, Snyder JM, Boggaram V, and Mendelson CR. Glucocorticoid regulation of the major surfactant associated protein (SP-A) and its messenger ribonucleic acid and of morphological development of human fetal lung in vitro. Endocrinology 123: 1712-1720, 1988.
35. Pratt WB, Galigniana MD, Morishima Y, and Murphy PJ. Role of molecular chaperones in steroid receptor action. Essays Biochem 40: 41-58, 2004.
36. Ramin SM, Vidaeff AC, Gilstrap LC III, Bishop KD, Jenkins GN, and Alcorn JL. The effects of dexamethasone and betamethasone on surfactant protein-B messenger RNA expression in human type II pneumocytes and human lung adenocarcinoma cells. Am J Obstet Gynecol 190: 952-959, 2004.
37. Rebuffat AG, Tam S, Nawrocki AR, Baker ME, Frey BM, Frey FJ, and Odermatt A. The 11-ketosteroid 11-ketodexamethasone is a glucocorticoid receptor agonist. Mol Cell Endocrinol 214: 27-37, 2004.
38. Sewell KJ, Shirley DG, Michael AE, Thompson A, Norgate DP, and Unwin RJ. Inhibition of renal 11beta-hydroxysteroid dehydrogenase in vivo by carbenoxolone in the rat and its relationship to sodium excretion. Clin Sci (Lond) 95: 435-443, 1998.
39. Suzuki S, Koyama K, Darnel A, Ishibashi H, Kobayashi S, Kubo H, Suzuki T, Sasano H, and Krozowski ZS. Dexamethasone upregulates 11beta-hydroxysteroid dehydrogenase type 2 in BEAS-2B cells. Am J Respir Crit Care Med 167: 1244-1249, 2003.
40. Suzuki T, Sasano H, Kaneko C, Ogawa S, Darnel AD, and Krozowski ZS. Immunohistochemical distribution of 11beta-hydroxysteroid dehydrogenase in human eye. Mol Cell Endocrinol 173: 121-125, 2001.
41. Walfisch A, Hallak M, and Mazor M. Multiple courses of antenatal steroids: risks and benefits. Obstet Gynecol 98: 491-497, 2001.